This application is based on new data from the applicant's laboratory indicating that the protein kinase IKKb may act to inhibit the insulin signaling pathway. This function is presumably a result of IKKb-mediated phosphorylation of one or more elements in the pathway whereby insulin receptor tyrosine kinase and its substrates are linked to glucose transport. Data presented in the application show decreased phosphorylation of IRS proteins in response to insulin when cells are transfected with IKKb, and also very significant effects of aspirin to reverse decreased IRS phosphorylation due to TNF and protein serine phosphatase inhibitors. Further, the applicant shows data indicating that poor glucose tolerance in insulin resistant mouse models such as ob/ob mice are ameliorated by aspirin treatment, which blocks IKKb. Based on these findings, the applicant proposes to test the hypothesis that the IKK signaling cascade is activated by conditions associated with insulin resistance and that inhibition of IKKb reverses insulin resistance by sensitizing the IR/IRS/ PI 3-kinase signaling cascade.
Specific aims i nclude attempts to determine upstream and downstream elements in the IKK pathway in respect to various models of insulin resistance. The mode of interaction of IKK with the IR/IRS proteins will also be approached. Other experiments will use animal models of insulin resistance to address the pharmacological profile for IKKb inhibition in vivo using various salicylates, and to directly determine the target of salicylate-mediated insulin sensitization. Finally, clinical studies are proposed to determine whether IKKb inhibition reverses insulin resistance in humans with impaired glucose tolerance.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Endocrinology Study Section (END)
Program Officer
Linder, Barbara
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Joslin Diabetes Center
United States
Zip Code
Woo, Ju Rang; Kim, Soon-Jong; Kim, Keon Young et al. (2017) The carboxy-terminal region of the TBC1D4 (AS160) RabGAP mediates protein homodimerization. Int J Biol Macromol 103:965-971
Goldfine, Allison B; Shoelson, Steven E (2017) Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk. J Clin Invest 127:83-93
Okazaki, Tatsuma; Liang, Feng; Li, Tong et al. (2014) Muscle-specific inhibition of the classical nuclear factor-?B pathway is protective against diaphragmatic weakness in murine endotoxemia. Crit Care Med 42:e501-9
Lee, Jongsoon; Miyazaki, Masaya; Romeo, Giulio R et al. (2014) Insulin receptor activation with transmembrane domain ligands. J Biol Chem 289:19769-77
Romeo, Giulio R; Pae, Munkyong; Eberlé, Delphine et al. (2013) Profilin-1 haploinsufficiency protects against obesity-associated glucose intolerance and preserves adipose tissue immune homeostasis. Diabetes 62:3718-26
Goldfine, A B; Conlin, P R; Halperin, F et al. (2013) A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance. Diabetologia 56:714-23
Kim, Myung-Sunny; Yamamoto, Yasuhiko; Kim, Kyungjin et al. (2013) Regulation of diet-induced adipose tissue and systemic inflammation by salicylates and pioglitazone. PLoS One 8:e82847
King, Aileen J F; Guo, Yongjing; Cai, Dongsheng et al. (2013) Sustained NF-?B activation and inhibition in ?-cells have minimal effects on function and islet transplant outcomes. PLoS One 8:e77452
Cipolletta, Daniela; Feuerer, Markus; Li, Amy et al. (2012) PPAR-? is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486:549-53
Romeo, Giulio R; Lee, Jongsoon; Shoelson, Steven E (2012) Metabolic syndrome, insulin resistance, and roles of inflammation--mechanisms and therapeutic targets. Arterioscler Thromb Vasc Biol 32:1771-6

Showing the most recent 10 out of 33 publications